Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of “Moderate Buy” by Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $36.56.

Several equities research analysts have recently commented on the stock. Royal Bank of Canada lowered their price target on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. UBS Group began coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company. KeyCorp started coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Bank of America assumed coverage on Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective for the company. Finally, Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a report on Tuesday, November 19th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of SGRY. KBC Group NV increased its position in Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after acquiring an additional 576 shares during the period. Quarry LP increased its holdings in shares of Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after purchasing an additional 1,760 shares during the period. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Surgery Partners by 747.6% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company’s stock worth $124,000 after purchasing an additional 3,379 shares during the period. Creative Planning bought a new stake in shares of Surgery Partners in the third quarter valued at approximately $258,000. Finally, Versor Investments LP acquired a new stake in Surgery Partners during the third quarter worth approximately $271,000.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $20.64 on Wednesday. The firm has a market capitalization of $2.62 billion, a PE ratio of -43.00, a price-to-earnings-growth ratio of 17.40 and a beta of 2.58. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. Surgery Partners has a 12-month low of $19.50 and a 12-month high of $35.29. The firm has a 50-day moving average price of $23.67 and a 200 day moving average price of $27.44.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.15 earnings per share. Research analysts anticipate that Surgery Partners will post 0.71 earnings per share for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.